Maze Therapeutics, Inc. (MAZE): SCHEDULE 13G filed May 9, 2025

Form type

SCHEDULE 13G

Filing date

May 9, 2025

Accession number

0001415889-25-012489

Filer

Maze Therapeutics, Inc. (CIK 1842295)